Larry Robbins's TMO Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 223,947 shares of Thermo Fisher Scientific Inc. (TMO) worth $129.77 M, representing 2.64% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 33 quarters.
Based on 13F filings, Larry Robbins has maintained a strategic position in TMO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2015, adding 2.35 M shares. Largest reduction occurred in Q1 2015, reducing 4.48 M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Thermo Fisher Scientific (TMO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Thermo Fisher Scientific (TMO) Trades by Larry Robbins
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -58,994 | Reduce 20.85% | 223,947 | $579.45 |
| Q3 2025 | +182,941 | Add 182.94% | 282,941 | $485.02 |
| Q2 2025 | +100,000 | New Buy | 100,000 | $405.46 |
| Q3 2020 | -81,555 | Sold Out | 0 | $0.00 |
| Q2 2020 | +81,555 | New Buy | 81,555 | $362.34 |
| Q1 2020 | -208,112 | Sold Out | 0 | $0.00 |
| Q4 2019 | -261,404 | Reduce 55.68% | 208,112 | $324.87 |
| Q3 2019 | -81,048 | Reduce 14.72% | 469,516 | $291.27 |
| Q2 2019 | -430,025 | Reduce 43.85% | 550,564 | $293.68 |
| Q1 2019 | -196,252 | Reduce 16.68% | 980,589 | $273.72 |
| Q4 2018 | -1.03 M | Reduce 46.75% | 1.18 M | $223.79 |
| Q3 2018 | -336,659 | Reduce 13.22% | 2.21 M | $244.08 |
| Q2 2018 | -416,142 | Reduce 14.05% | 2.55 M | $207.14 |
| Q1 2018 | -364,833 | Reduce 10.96% | 2.96 M | $206.46 |
| Q4 2017 | +598,749 | Add 21.94% | 3.33 M | $189.88 |
| Q3 2017 | -31,138 | Reduce 1.13% | 2.73 M | $189.20 |
| Q2 2017 | -212,095 | Reduce 7.14% | 2.76 M | $174.47 |
| Q1 2017 | -687,674 | Reduce 18.79% | 2.97 M | $153.60 |
| Q4 2016 | +973,418 | Add 36.24% | 3.66 M | $141.10 |
| Q3 2016 | -171,924 | Reduce 6.02% | 2.69 M | $159.06 |
| Q2 2016 | -752,312 | Reduce 20.84% | 2.86 M | $147.76 |
| Q1 2016 | -2.32 M | Reduce 39.15% | 3.61 M | $141.59 |
| Q4 2015 | -2.58 M | Reduce 30.29% | 5.93 M | $141.85 |
| Q3 2015 | -748,506 | Reduce 8.08% | 8.51 M | $122.28 |
| Q2 2015 | +2.35 M | Add 33.99% | 9.26 M | $129.76 |
| Q1 2015 | -4.48 M | Reduce 39.31% | 6.91 M | $134.34 |
| Q4 2014 | +11,598 | Add 0.10% | 11.39 M | $125.29 |
| Q3 2014 | +433,474 | Add 3.96% | 11.38 M | $121.70 |
| Q2 2014 | +1.38 M | Add 14.45% | 10.94 M | $118.00 |
| Q1 2014 | +1.03 M | Add 12.02% | 9.56 M | $120.24 |
| Q4 2013 | +451,432 | Add 5.58% | 8.54 M | $111.35 |
| Q3 2013 | -425,000 | Reduce 4.99% | 8.08 M | $92.15 |
| Q2 2013 | +8.51 M | Add 0.00% | 8.51 M | $84.63 |
Larry Robbins's Thermo Fisher Scientific Investment FAQs
Larry Robbins first purchased Thermo Fisher Scientific Inc. (TMO) in Q2 2013, acquiring 8,508,661 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Thermo Fisher Scientific Inc. (TMO) for 33 quarters since Q2 2013.
Larry Robbins's largest addition to Thermo Fisher Scientific Inc. (TMO) was in Q2 2013, adding 8,508,661 shares worth $720.09 M.
According to the latest 13F filing for Q4 2025, Larry Robbins's firm, Glenview Capital Management, LLC, owns 223,947 shares of Thermo Fisher Scientific Inc. (TMO), valued at approximately $129.77 M.
As of the Q4 2025 filing, Thermo Fisher Scientific Inc. (TMO) represents approximately 2.64% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings.
Larry Robbins's peak holding in Thermo Fisher Scientific Inc. (TMO) was 11,387,265 shares, as reported at the end of Q4 2014.